Novartis Seen 'Saving Face' With Idenix Hep C Deal (Interferon)
Novartis Seen 'Saving Face' With Idenix Hep C Deal
Forbes - Mar 29 10:55 AM
Analysts were divided on the potential of Idenix's lead drug candidate.Save to My Web
(AFX UK Focus) 2006-03-29 20:58 GMT: Avian flu expected in U.S. this spring; stocks ignited - UPDATE 1
Interactive Investor - Mar 29 12:39 PM
NEW YORK (AFX) -- U.S. government officials monitoring the spread of avian influenza are expecting the first case to reach Alaska in about three weeks and to hit the West Coast by autumn, Prudential Equity Group said Wednesday.Save to My Web
Serono Submits New Formulation of Rebif(R) for Approval in the United States and in Europe
FinanzNachrichten - Apr 03 10:23 PM
GENEVA, Switzerland, and ROCKLAND, Massachusetts, April 4 /PRNewswire-FirstCall/ -- Serono ( Nachrichten ) (virt-x:SEO and NYSE: SRA) announced today the submission of a supplemental Biologics Licence Application (sBLA) to the US Food and Drug Administration (FDA) and of a variation to the current Marketing Authorization to the European Medicines Agency (EMEA) for a new formulation of Rebif(R) Save to My Web
New drug to fight Hepatitis B now available
Channel News Asia via Yahoo! Asia News - Apr 01 8:17 AM
SINGAPORE : Chronic Hepatitis B carriers now have another drug to help them fight the virus.Save to My Web
Drugmakers find new ways to battle flu
KARE 11 Minneapolis-St. Paul - Mar 29 11:48 AM
Concern that the world could be vulnerable to a flu pandemic has spurred drug companies' efforts to search for new weapons against fluSave to My Web

<< Home